Amid Purdue Pharma Controversy, Calls for Overhaul in Mass Tort Laws Gain Momentum
Washington, D.C. — As legal battles loom large over corporate America, with the opioid crisis and Purdue Pharma at the forefront, the clamor for significant mass tort reform grows louder. These complex legal confrontations, involving multiple plaintiffs and extensive allegations of harm caused by companies, underscore the urgent need for a revamp of the system that many argue is no longer fit for its intended purpose. Mass tort cases are quintessentially large-scale, involving numerous individuals against one or several corporate entities. The Purdue Pharma case, tied to the opioid epidemic, is a prime example. It … Read more